Preprint
Article
18 Months Follow-Up of Deep Molecular Response 4.5 (MR4.5) with Nilotinib in Patients with Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Prospective, Multi-Center Study in China
This version is not peer-reviewed.
Submitted:
11 June 2023
Posted:
13 June 2023
You are already at the latest version
A peer-reviewed article of this preprint also exists.
Abstract
Keywords:
Subject:
Medicine and Pharmacology - Clinical MedicineCopyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Alerts
MDPI Initiatives
Important Links
© 2025 MDPI (Basel, Switzerland) unless otherwise stated